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Assessment of dry weight by monitoring changes in blood
volume during hemodialysis using Crit-Line.
Background. Routine assessment of dry weight in chronic
hemodialysis patients relies primarily on clinical evaluation of
patient fluid status. We evaluated whether measurement of
postdialytic vascular refill could assist in the assessment of dry
weight.
Methods. Twenty-eight chronic, stable hemodialysis patients
were studied during routine treatment sessions using constant
dialysate temperature and dialysate sodium concentration,
and relative changes in blood volume were monitored using
Crit-Line III monitors throughout this study. The study was
divided into three phases. Phase 1 studies evaluated the time-
dependence of vascular compartment refill after completion of
hemodialysis. Phase 2 studies evaluated the relationships in pa-
tient subgroups between intradialytic changes in blood volume
and the presence of postdialytic vascular compartment refill
during that last 10 minutes of hemodialysis after stopping ul-
trafiltration. Phase 3 studies evaluated the extent of dry weight
changes following the application of a protocol for blood vol-
ume reduction, postdialytic vascular compartment refill, and
correlation with clinical evidence of intradialytic hypovolemia
and/or postdialytic fatigue. Phase 3 included anywhere from
three to five treatments.
Results. Phase 1 studies demonstrated that despite inter-
patient variability in the magnitude of postdialytic vascular
compartment refill, when significant refill was evident, it always
continued for at least 30 minutes. However, the majority of
refill took place within 10 minutes postdialysis. Phase 2 studies
identified 3 groups of patients: those who exhibited intradialytic
reductions in blood volume but not postdialytic vascular com-
partment refill (group 1), those who exhibited intradialytic
reductions in blood volume and postdialytic vascular compart-
ment refill (group 2), and those whose blood volume did not
change substantially during hemodialysis treatment (group 3).
In phase 3 studies, use of an ultrafiltration protocol for blood
volume reduction and monitoring of postdialytic vascular com-
partment refill combined with clinical assessment of hypov-
olemia and postdialytic fatigue demonstrated that patients often
had a clinical dry weight assessment which was too low or too
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high. In all 28 patients studied, dry weight was either increased
or decreased following use of this protocol.
Conclusion. Determination of the extent of both intradialytic
decreases in blood volume and postdialytic vascular compart-
ment refill, combined with clinical assessment of intradialytic
hypovolemia and postdialytic fatigue, can help assess patient
dry weight and optimize volume status while reducing dialysis
associated morbidity. The number of hospital admissions due
to fluid overload may be reduced.
Continuous monitoring of relative changes in blood
volume during hemodialysis has been reported to al-
low more timely prediction of impending intradialytic
morbid events and improved assessment of patient dry
weight. Accurate prediction of hypotension and intradi-
alytic morbidity using blood volume monitoring has been
achieved in many studies [1–3], but such results have not
been universally observed [4]. Intradialytic hypotension
is particularly difficult to predict using only blood volume
monitoring since it is also a function of a number of other
physiologic parameters, such as body temperature [5, 6].
Further, the use of biofeedback control devices based on
blood volume monitoring have been shown to result in
more effective removal of excess body fluid during rou-
tine hemodialysis [7–12].
The use of continuous blood volume monitoring dur-
ing hemodialysis treatments to improve assessment of pa-
tient dry weight has also shown considerable promise. For
example, Lopot et al [13] suggested that the lack of a sub-
stantial change in blood volume during hemodialysis in-
dicated that dry weight was too high. Consistent with this
hypothesis, a negative association was recently reported
between relative changes in blood volume and postdialy-
sis (especially systolic) blood pressure [14]. Moreover,
Steuer et al [15] have used this concept to adjust dry
weight in ten chronic hemodialysis patients who had lit-
tle intradialytic change in blood volume during routine
therapy. These investigators were able to increase ultra-
filtration volume in eight patients, which led to a decrease
in dry weight in six of those eight patients. Additional
testing of this hypothesis has not yet been described.
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Previous work by others [16] has shown that blood
volume often increases immediately following routine
hemodialysis treatments because the vascular refilling
rate remains high even after stopping ultrafiltration. In
this study, we tested whether changes in blood volume
both during as well as immediately following hemodialy-
sis treatment (postdialytic vascular compartment refill)
provided information to permit more accurate assess-
ment of dry weight.
METHODS
Patients
Twenty eight chronic, stable hemodialysis patients
treated three times per week from the Grass Valley Dial-
ysis Unit (Grass Valley, CA, USA) were recruited to par-
ticipate in these studies. The mean age was 68 ± 13 years
(range 39 to 88 years), and 18 patients were older than
60 years. All patients studied were Caucasian; no African
American, Hispanic, Native American or Asian patients
were included in the study. This feature of the study was
not due to patient selection but rather to the unique de-
mographics of the study population in rural Northern
California. Twenty seven of the 28 patients had one or
more of the following co morbidities: hypertension and/or
intradialytic hypotension, diabetes mellitus, chronic ob-
structive pulmonary disease, coronary arteriosclerosis,
and congestive heart failure. Nineteen patients were hy-
pertensive and 12 were diabetics.
Hemodialysis treatments
Routine hemodialysis was performed according to the
prescription of the clinic’s nephrologist. Hemodialysis
was performed using Fresenius 2008H hemodialysis mon-
itors (Fresenius Medical Care North America, Lexington,
MA, USA) and either low flux (GFS Plus 20) (Gambro
Healthcare, Lakewood, CO, USA) or high flux (Polyflux
17R, Polyflux 21R, and Polyflux 24R) (Gambro Health-
care) dialyzers. All dialyzers were reprocessed using Re-
nalin(tm) as germicide. The ultrafiltration rate was main-
tained constant during treatments in phase 1 and 2 stud-
ies (see below). In phase 1 studies, ultrafiltration rate was
calculated as the difference between predialysis and post-
dialysis weight divided by treatment time minus time nec-
essary to assess refill (10, 20, or 30 minutes). In phase
2 and 3 studies, the ultrafiltration rate was calculated
as the difference between predialysis and postdialysis
weight divided by treatment time, minus 10 minutes (see
detailed description of study phases below). Dialysate
temperature was kept constant at 37◦C. No sodium mod-
eling was used, and dialysate sodium concentration was
maintained constant at 140 mEq/L. Average blood flow
was 450 mL/m for fistulas and grafts and 350 mL/m for
catheters. Dialysate flow was 800 mL/m. Dialysis treat-
ment time was modified in order to achieve a single-pool
Kt/V (spKt/V) for urea greater than 1.4. The following
signs and symptoms of intra dialytic hypovolemia were
recorded: nausea, vomiting, dizziness, cramps, hypoten-
sion, and malaise. In addition, patients were routinely
interrogated for occurrence of sustained, postdialytic fa-
tigue and weakness (“Can you return to your normal
daily activities within 2 hours after finishing dialysis treat-
ments?”). During each study, continuous blood volume
monitoring was performed using the Crit-Line III Moni-
tor (CLM III) according to the instructions of the manu-
facturer (Hema Metrics, Kaysville, UT, USA).
Clinical assessment of estimated dry weight
Patients in the study were under the care of a board-
certified nephrologist, who was also the Dialysis Clinic
Medical Director, and a certified nephrology nurse, who
acted as the Clinic Center Director. Together they were
responsible for assigning and periodically reassessing dry
weights. Estimated dry weight was defined as the lowest
weight the patient could tolerate that will render him or
her edema free at the end of dialysis, without the develop-
ment of symptoms of hypovolemia (hypotension, cramp-
ing, nausea, vomiting) [17]. In addition, estimated dry
weight was revised down if postdialysis blood pressure
was > 140/90 mm Hg and/or predialysis blood pressure
exceeded 170/90 mm Hg, irrespective of the presence or
absence of postdialysis edema. Estimated dry weight was
reviewed on all patients at least once a month. None of the
patients included in the study had cramps/hypotension or
post dialysis edema.
Interpretation of blood volume monitoring using
the CLM III
The CLM III yields a continuous recording of changes
in hematocrit in response to ultrafiltration. As fluid is re-
moved from the intravascular compartment, hematocrit
rises steadily and hematocrit changes are a mirror re-
flection of percent reductions in blood volume [18]. The
CLM III is manufactured with the capability to detect
hematocrit changes of 0.1% and very low signal noise
and these features are routinely validated at the Hema
Metrics blood laboratory.
This is attested to by the ability of the system to record
nearly instantaneous, demonstrable increases in blood
volume following administration of salt-poor albumin
solutions (see Fig. 1). It has long been known that as
blood volume is gradually reduced, cardiac output de-
clines when blood volume is reduced by approximately
8% and hypotension occurs at blood volume reductions
of ≥15% [19]. Figure 2A shows a typical CLM III record-
ing in which blood volume was reduced steadily during
a 3-hour dialysis session. Total blood volume reduction
was 16% and patient had no clinical evidence of hypov-
olemia. Figure 2B shows a CLM III recording in which
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Fig. 1. Blood volume response to albumin administration. Abbrevia-
tions are: A, albumin intravenous initiated; B, albumin intravenously
completed; C, ultrafiltration rate 1800 mL/hour; D, ultrafiltration rate
2000 mL/hour.
5
0
−10
−20
%
BV
1 2 3 4
UF OFF
B
5
0
−10
−20
%
BV
1 2 3 4UF OFF
A
5
0
−10
−20
1 2 3 4
UF OFF
C
%
BV
Fig. 2. Actual Crit-Line print out sheets showing typical percent blood
bolume (BV) reduction and absence or presence of postdialytic vascular
refilling in graphic form. (A) Blood volume reduced by 16%; no post
dialytic vascular refilling. (B) Blood volume reduced by 12%; clear-
cut postdialytic vascular refilling. (C) Blood volume reduced by 6%;
no postdialytic vascular refilling. The vertical axis in Figures 1 and 2
to C represents a% change in blood volume while the horizontal axis
represents dialysis time in hours.
blood volume was reduced by 12% in a dialysis session
lasting 3 hours and 15 minutes. Continuous monitoring
after finishing ultrafiltration shows a clear-cut linear in-
crease in blood volume that persisted for over 30 min-
utes and indicates “vascular refilling.” The presence of
“vascular refilling” was interpreted as indication that pa-
tient had fluid excess at the end of dialysis and dry weight
should be lower than postdialysis weight. Figure 2C de-
picts a CLM III recording in which blood volume de-
creased by 6% during a dialysis session lasting 3 hours
and 45 minutes. Continuous monitoring after discontin-
uing ultrafiltration showed no demonstrable increase in
blood volume (“vascular refilling”), and patient had no
clinical evidence of hypovolemia. This was interpreted as
indication that patient had no fluid excess at the end of
dialysis and postdialysis weight was equal to dry weight.
Study design
The study was performed in three sequential phases.
Phase 1 studies evaluated the time-dependence of vas-
cular compartment refill after completion of a routine
hemodialysis treatment. In these studies, changes in
blood volume were continuously monitored for various
times after completion of the prescribed hemodialysis
treatment and the cessation of fluid removal. Twelve pa-
tients were divided into three groups of four patients,
each of which were followed for 10, 20, or 30 minutes
after the completion of ultrafiltration treatments, respec-
tively. The length of the hemodialysis treatment remained
unchanged from prescription.
Phase 2 studies evaluated the extent of postdialytic
vascular compartment refill in 28 patients. During these
treatments, the rate of fluid removal was adjusted to en-
sure that the prescribed volume was removed 10 minutes
before completion of the treatment. Blood volume mon-
itoring was continuously performed for the entire treat-
ment; thus, blood volume changes both during and after
stopping ultrafiltration were monitored without altering
the prescribed dialysis dose. This procedure was followed
for three consecutive hemodialysis treatments, and the
magnitude of intradialytic reduction in blood volume was
noted with respect to the presence of postdialytic vascular
compartment refill. For these and all subsequent studies,
a significant reduction in blood volume during hemodial-
ysis was defined as one greater than 3% per hour and
the presence of postdialytic vascular compartment refill
was defined as a steady increase in blood volume for 10
minutes after stopping ultrafiltration.
Phase 3 studies examined the occurrence of postdi-
alytic vascular refilling and clinical evidence of intra-
dialytic hypovolemia and postdialytic fatigue in all the
patients examined in phase 2 studies, after altering the
rate of ultrafiltration to achieve an intradialytic reduction
in blood volume of approximate 8% in the first hour and
<4% per hour thereafter, up to a total blood volume re-
duction not to exceed 16%. This protocol has been used
successfully in previous studies [20]. The protocol was
followed for three to five treatments and was designed
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Table 1. No hematocrit change after stopping ultrafiltration (no refill present)
Hematocrit Hematocrit Hematocrit
Patient number with ultrafiltration off 10 minutes after ultrafiltration off decrease-10 minutes after ultrafiltration off
2 39.2 39.0 0.2
This table shows minimal hematocrit change after the ultrafiltration was turned off.
Table 2. Hematocrit decrease after stopping ultrafiltration (refill present)
Hematocrit Hematocrit Hematocrit
Patient number with ultrafiltration off 10 minutes after ultrafiltration off decrease-10 minutes after ultrafiltration off
13 42.5 41.0 1.5
14 39.4 38.4 1.0
15 28.3 27.8 0.5
17 37.5 36.0 1.5
19 45.3 44.3 1.0
This table shows significant hematocrit change after the ultrafiltration was turned off.
based on previous studies which have suggested that such
reductions in blood volume during hemodialysis reduce
intradialytic symptoms and maximize fluid removal [21].
The approach used to revise dry weight in phase 3 stud-
ies is described in the Results section and summarized in
Table 3.
RESULTS
The extent of intradialytic changes in blood volume
and postdialytic vascular compartment refill in phase 1
studies showed high interpatient variability. When post-
dialytic vascular compartment refill was evident, blood
volume continued to increase in all patients for the en-
tire period of observation (10 to 30 minutes) after com-
pleting the hemodialysis session. Even after 30 minutes,
there was no indication that postdialytic vascular com-
partment refill was complete. However, the majority of
refill took place within 10 minutes postdialysis. For practi-
cal reasons, therefore, the presence of postdialytic vascu-
lar compartment refill was arbitrarily evaluated in subse-
quent studies as the postdialytic increase in blood volume
10 minutes after stopping ultrafiltration.
Table 1 shows hematocrit values of a treatment where
hematocrit did not change after discontinuing ultrafiltra-
tion. Table 2 shows hematocrit values of five separate
treatments where hematocrit decreased after discontin-
uing ultrafiltration. A decrease in hematocrit ≥0.5%,
within 10 minutes after stopping ultrafiltration, was con-
sidered to reflect a significant increase in blood vol-
ume, representing postdialytic vascular compartment
refill. The recorded decreases in hematocrit in these five
patients reflected postdialytic increases in blood volume
ranging from 1.8% to 3.7%.
With one exception, the dry weights assigned to all pa-
tients at the beginning of the study met the clinical cri-
teria previously described. The single exception was an
elderly patient with persistent pedal edema on whom ul-
trafiltration was consistently hampered by cramping and
hypotension. This patient displayed clear-cut evidence of
vascular refilling. It is of interest to note that this prob-
lem, which is often encountered in clinical practice, also
occurred under conditions of ultrafiltration with careful
control of blood volume changes. This particular patient
had no evidence of cardiac, hepatic or pulmonary dis-
ease, was not taking antihypertensive medications and
showed no evidence of hypoxemia during ultrafiltration.
It is possible that in some elderly individuals, vascular
refilling is too sluggish or that they possess a chronic in-
crease of the interstitial fluid volume, without concomi-
tant hypervolemia. This is known to occur transiently in
certain “acute” clinical conditions such as sepsis and the
period immediately after surgery and anesthesia.
Phase 2 studies illustrated interpatient variability in in-
tradialytic changes in blood volume and changes in blood
volume that occurred during the last 10 minutes of treat-
ment after stopping ultrafiltration (defined as postdialytic
vascular compartment refill). Based on these changes in
blood volume, patients studied during phase 2 studies
could be categorized into three distinct groups as indi-
cated in Table 3.
The patient characteristics of these groups are com-
pared in Table 3 and are graphically represented in
Figure 3. There were no differences in the baseline es-
timated dry weight among the three groups of patients as
determined by one-way analysis of variance (ANOVA)
(P = 0.77). However, the mean difference between “es-
timated dry weight” by clinical assessment before the
study and dry weight determined by blood volume mon-
itoring with CLM III was −1.25 ± 2.97 kg for the en-
tire population as determined by a Student paired t test
(P = 0.03). In addition, the mean difference between
“estimated dry weight” by clinical assessment before
the study and dry weight determined by blood volume
monitoring with CLM III varied among different groups
(+0.53 ± 1.68, −0.91 ± 2.16, and −5.38 ± 2.18 kg for
858 Rodriguez et al: Assessment of dry weight during hemodialysis
Table 3. Patient characteristics in phase 2 studies
Group 1 Group 2 Group 3
(blood volume reduction/ (blood volume reduction/ (no blood
Patients no vascular refilling) vascular refilling) volume reduction)
Total number 12 10 6
Age years 71 ± 17 68 ± 11 63 ± 9
Males/females number 9/3 6/4 6/0
Diabetics number 5 2 3
Residual renal functiona number 6 1 0
Average baseline estimated dry weight kg 75.7 76.5 81.4
Average pre-blood pressure (prestudy) mm Hg 146/74 159/80 138/82
Average pre-blood pressure (poststudy) mm Hg 140/72 149/75 142/70
aUrine volumes greater than 600 mL/day.
2
1
0
−1
−2
−3
−4
−5
−6
−7
kg
−0.53 ± 1.63
−0.91 ± 2.16
−5.38 ± 2.18
Group1 Group 2 Group 3
Fig. 3. A bar chart indicating the dry weight changes among the three
groups. The change in dry weight is based on the difference between
estimated dry weight (prestudy) and the actual dry weight at the con-
clusion of the study. Group 1 patients exhibited significant intradialytic
reductions in blood volume but no postdialytic vascular compartment
refill. Group 2 patients exhibited significant intradialytic reductions in
blood volume and significant postdialytic vascular compartment refill.
Group 3 patients did not exhibit significant intradialytic reductions in
blood volume.
groups 1, 2, and 3, respectively). Only the group 3 change
in dry weight was statistically significant as determined
by a Student paired t test (P = 0.002). The first group
comprised 12 patients who experienced significant intra-
dialytic reductions in blood volume (>3% per hour) but
no postdialytic vascular compartment refill. This group
(group 1) was called “blood volume reduction/no vas-
cular refilling.” In this group, the average dry weight
obtained by blood volume monitoring and postdialytic
vascular refilling combined with clinical evidence of hy-
povolemia and post dialysis fatigue was 0.5 kg higher
than the “estimated dry weight” obtained by clinical as-
sessment. The second group comprised 10 patients who
experienced significant intradialytic reductions in blood
volume (>3% per hour) and also exhibited postdialytic
vascular compartment refill. This group (group 2) was
termed “blood volume reduction/vascular refilling” In
this group, the average dry weight obtained by blood vol-
ume monitoring and postdialytic vascular refilling com-
bined with clinical evidence of hypovolemia and post-
dialysis fatigue was 0.91 kg lower than the “estimated
dry weight” obtained by clinical assessment. The third
group comprised six patients whose blood volume did
not change substantially during hemodialysis (<3% per
hour). This group was termed “no blood volume reduc-
tion.” In this group, the average dry weight obtained by
blood volume monitoring and postdialytic vascular refill-
ing combined with clinical evidence of hypovolemia and
postdialysis fatigue was 5.38 kg lower than the “estimated
dry weight” obtained by clinical assessment. Group 1 pa-
tients had residual renal function more often than pa-
tients in groups 2 and 3. All of the six patients in group
3 had cardiac disease (coronary arteriosclerosis and/or
congestive heart failure) and five out of the six were di-
abetics. Two of the patients in group 3 had three comor-
bidities (hypertension, diabetes, cardiac disease). Taken
together, these results indicate that in patients with signif-
icant reduction of blood volume but without postdialytic
vascular refilling, postdialysis weight may underestimate
dry weight. On the other hand, in patients with postdi-
alytic vascular refilling in spite of significant reduction
of blood volume as well as in patients without significant
reduction of blood volume, postdialysis weight may over-
estimate dry weight.
All 28 phase 2 patients entered the interventional phase
3 part of this study. In this study, blood volume was re-
duced within the first hour of dialysis by approximately
8%. After the first hour, blood volume reduction was
maintained at <4% per hour up to a total blood vol-
ume reduction not to exceed 16%. These levels of blood
volume reduction were maintained by altering the ultra-
filtration rate manually during each treatment by the re-
search staff, similar to that reported previously [20, 21].
The increase in blood volume after stopping ultrafiltra-
tion during the last 10 minutes of treatment (postdialytic
vascular compartment refill) was also assessed in each
study treatment. After the first dialysis session using this
protocol, patients were analyzed based on changes in
blood volume using the CML III and the presence or
absence of symptoms of hypovolemia during the treat-
ment (i.e., hypotension, cramping, dizziness) and/or post
dialysis weakness and fatigue (Table 4). The following
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Table 4. Assessment of dry weight based on changes in blood
volume, postdialytic vascular compartment refill and symptoms of
hypovolemia
Symptoms of
Blood Postdialytic hypovolemia/ Dry
volume vascular postdialysis weight
reduction refill fatigue change
Yes No No No
Yes No Yes Revise upa
Yes Yes No Revise down
Yes Yes Yes Revise downb
No No No Revise down
aIn some of these patients a decline in blood volume was noted during the
observation period for postdialytic vascular compartment refill.
bAchieving dry weight in these patients requires individualizing dialysis
treatments by changes in blood flow, duration of sessions, ultrafiltration modeling,
monitoring of oxygen saturation, and the use of colloid solutions.
responses were examined, for the purpose of revising “es-
timated dry weight” obtained by clinical assessment: (1) if
no postdialytic vascular compartment refilling was noted
and the patient did not experience symptoms of hypov-
olemia and/or postdialytic fatigue, the patient postdialy-
sis weight was considered to be the dry weight; (2) if no
postdialytic vascular compartment refill occurred and the
patient did experience symptoms of hypovolemia and/or
postdialytic fatigue, the postdialysis weight was consid-
ered to be below the dry weight and the dry weight was
revised up; (3) if postdialytic vascular compartment refill
was evident, with or without symptoms of hypovolemia
and postdialysis fatigue, the postdialysis weight was con-
sidered to be above the dry weight and the dry weight
was revised down; and (4) if no reduction in blood vol-
ume could be documented with the CML III, the post-
dialysis weight was considered to be above the dry weight
and the dry weight was revised down. These patterns are
summarized in Table 4.
After three to five treatments using this protocol, the
dry weight achieved by blood volume monitoring with the
CLM III was compared with the originally “estimated dry
weight” based on clinical criteria. In all 28 patients studied
in phase 3, the dry weight achieved by monitoring blood
volume and postdialytic vascular compartment refill with
the CLM III was different than the dry weight estimated
by clinical criteria (Tables 5 and 6). Nineteen (67.9%)
patients had their dry weight reduced; the mean age of
these patients was 65 ± 17 years. Nine patients (32.1%)
had their dry weight increased; the mean age of these pa-
tients was 68 ± 13. Of the 19 patients whose dry weight
was reduced, 13 patients had their dry weight reduced by
more than 1 kg. Of the nine patients whose dry weight
was increased, seven had their dry weight increased by
more than 1 kg. After altering the rate of ultrafiltration
according to the protocol in these phase 3 studies, all pa-
tients now had significant reductions in blood volume dur-
Table 5. Patients who had a dry weight increase
Estimated dry Dry weight Difference
Patient weight by by CLM III in dry
number Age clinical criteria kg kg weight kg
2 80 72.5 74.6 2.10
3 55 57.5 58.8 1.30
6 79 81 82.5 1.50
7 39 113 116.1 3.10
9 77 55 55.3 0.30
11 41 80.5 83.3 2.80
13 56 66.5 70.2 3.70
18 80 74 75.2 1.20
22 83 91 91.4 0.40
CLM III is Crit-Line III monitor
Table 6. Patients who had a dry weight decrease
Estimated dry Dry weight Difference
Patient weight by by CLM III in dry
number Age clinical criteria kg kg weight kg
1 88 72 71.7 −30
4 68 52 51.5 −50
5 77 68 67.9 −10
8 81 76 75.4 −60
10 78 100 97.3 −2.70
12 84 80.5 79.9 −60
14 65 51.5 51.3 −20
15 69 81 78.6 −2.40
16 73 75 72.4 −2.60
17 70 78.5 76.9 −1.60
19 57 58.5 55.3 −3.20
20 77 109 107 −2.00
21 52 80 77.6 −2.40
23 78 78 75 −3.00
24 59 75.5 70.6 −4.90
25 52 104.5 98.4 −6.10
26 69 69.5 66.6 −2.90
27 59 75.5 67.3 −8.20
28 61 85.5 78.3 −7.20
CLM III is Crit-Line III monitor. Changes in dry weight by blood volume
monitoring and postdialytic vascular compartment refilling using ultrafiltration
protocol in phase 3 studies.
ing hemodialysis and postdialytic refilling of the vascular
compartment was not evident.
Ten of the 13 patients who had their dry weight re-
duced by more than 1 kg also experienced a reduction in
blood pressure. The mean reduction for these patients
was 17 mm Hg for systolic and 13 mm Hg for dias-
tolic blood pressure: 157/81 prestudy vs. 140/68 poststudy.
Most of these patients were off blood pressure medica-
tions before the study. The others had their blood pres-
sure medications discontinued or the dose reduced.
The number of hospitalizations from the Grass Valley
Dialysis Unit for problems related to “fluid overload”
was reduced from 15 admissions, during the 12 months
prior to introducing the CLM III to one admission over
the 18 months, following the regular use of the CLM III
to assign dry weights.
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DISCUSSION
Continuous blood volume monitoring during
hemodialysis cannot define dry weight directly since
intradialytic changes in blood volume only reflect
those occurring within the plasma compartment, not
those within the extracellular compartment [22, 23].
Nevertheless, the fluid composition of the extracellular
compartment can indirectly reflect intradialytic changes
in blood volume by controlling the vascular refilling
rate [24]. Indeed, de Vries et al [25] have shown that
intradialytic changes in blood volume were larger
in dehydrated and normohydrated patients than in
overhydrated patients. The primary hypothesis of this
study was that intradialytic changes in blood volume
and postdialytic refill of the vascular compartment are
both indirectly controlled by the extracellular fluid
status and may indirectly reflect the hydration status of
the extracellular fluid compartment, and therefore dry
weight assessment.
Our findings in phase 1 studies that postdialytic refill of
the vascular compartment extended for periods as long as
30 minutes is consistent with previous work by Katzarski
et al [16]. Those workers reported that postdialytic refill
of the vascular compartment was dependent on the length
of the hemodialysis treatment and continued for at least
60 minutes in dialysis treatments of 3 hours in duration.
Thus, our use of the 10-minute period after stopping ultra-
filtration to determine the presence of significant vascular
compartment refill is appropriate.
The results reported in this study confirm previous
work by Lopot et al [13] and Steuer et al [15] in showing
that patients who do not exhibit a substantial reduction in
blood volume during hemodialysis remain overhydrated
at the end of dialysis. In this study, all six group 3 patients
who did not exhibit substantial intradialytic reductions in
blood volume in phase 2 studies reduced their dry weight
by more than 1 kg during phase 3 studies. Such reductions
in dry weight were also frequently accompanied by de-
creases in both systolic and diastolic blood pressure. The
observation that the patients who experienced the largest
reduction in estimated dry weight (−5.38 kg in group
3) also had significant comorbidities (heart disease, di-
abetes mellitus) implies that the difficulties encountered
during ultrafiltration of these patients invariably result in
overestimation of their dry weights and chronic hyperv-
olemia which in turn may compromise their cardiac status
further. Appropriate use of the CLM III in this group
of patients would allow optimization of their volume
status while minimizing the occurrence of intradialytic
hypovolemia.
In patients with significant blood volume reduction but
without postdialytic vascular compartment refilling, the
postdialysis weight was equal to the dry weight. How-
ever, if these patients experienced intradialytic symp-
toms of hypovolemia and/or postdialysis weakness and
fatigue, the postdialysis weight was invariably lower than
the dry weight. In five of six patients who experienced
these symptoms, dry weight was increased by ≥1 kg and
all intradialytic and postdialytic morbid complications
were eliminated. These findings are consistent with the
view that the lack of postdialytic vascular refilling de-
spite significant reductions in blood volume may indicate
excessive reduction of extracellular fluid volume by ultra-
filtration. Recognizing these patients and appropriately
revising dry weights up will be likely to reduce intradia-
lytic interventions by dialysis staff and improve patients
well being during and after dialysis treatments. The value
of blood volume monitoring in achieving target weight
in pediatric hemodialysis patients has been reported re-
cently [26].
In patients with postdialytic vascular compartment
refilling despite significant reduction of blood volume,
postdialysis weight could be reduced without occurrence
of clinical evidence of intradialytic hypovolemia and/or
postdialytic fatigue. This is consistent with the notion that
the presence of postdialytic vascular refill is indication
of extracellular fluid expansion and overhydration at the
end of dialysis, despite absence of clinical signs of fluid
excess. This approach may prove to be invaluable in op-
timizing volume status of patients with minimal or no
clinical signs of fluid excess. A small group of patients
with postdialytic vascular compartment refilling do expe-
rience symptoms of hypovolemia that preclude appropri-
ate reductions of dry weight. One plausible explanation
for these findings is that the rate of vascular refilling is
slower than the rate of fluid removal from intravascular
compartment, under prescribed conditions for ultrafiltra-
tion, and intradialytic reduction of blood volume is thus
accompanied by intradialytic morbidity. If this is the case,
it follows that longer dialysis sessions and/or lower blood
flow rates may allow the removal of additional fluid vol-
umes and to achieve euvolemia. The present studies do
not allow us to answer this question.
It is possible that the dry weight obtained by moni-
toring blood volume reduction and postdialytic vascular
compartment refilling with the CLM III in combination
with clinical assessment of intradialytic hypovolemia and
postdialytic fatigue is not synonymous with the achieve-
ment of euvolemia and normalization of extracellular
fluid volume status. To answer this question would require
simultaneous determination of extracellular fluid volume
by independent methods (i.e., bioimpedance plethys-
mography, volume of distribution of extracellular fluid
markers, ultrasound monitoring of inferior vena cava).
Nevertheless, we believe the approach used in these stud-
ies provides an objective way of optimizing fluid status
while reducing intra- and postdialytic morbidity and sig-
nificantly improving patients well being.
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Clinical assessment of “estimated dry weight,” as done
in the present study, has been for years the standard of
care in the dialysis community. Our observations suggest
that the “best clinical assessment” of dry weight fails to
optimize volume status and reduce dialysis morbidity.
Accurate assessment of dry weight in dialysis patients
continues to be a challenge. Most “objective” methods
available are cumbersome, expensive and not readily
available. The CLM III provides an inexpensive, noninva-
sive, easy to perform alternative. When used in combina-
tion with clinical assessment, it results in optimization of
extracellular fluid status, reduction of intra- and postdial-
ysis morbid complications, and improvement in patients’
well being and potential reduction in hospitalizations due
to fluid overload. The value of blood volume monitoring
in achieving target weight in pediatric hemodialysis pa-
tients has been reported recently [26].
CONCLUSION
This study demonstrated that application of the ultra-
filtration protocol and postdialytic vascular compartment
refilling described in phase 3 studies, when used in com-
bination with clinical assessment of hypovolemia and/or
postdialysis fatigue, provides an objective way of assign-
ing dry weight, reducing morbidity, and improving patient
well-being. In addition, the possibility that costs associ-
ated with hospitalizations for fluid overload may be re-
duced should be investigated further.
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